CAMBRIDGE, MASS.--(Business Wire / Korea Newswire)--ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced that Amit D. Munshi, Chief Executive Officer, will virtually present at the Evercore ISI 2024 Emerging Biotech Conference on Thursday, February 29, 2024, at 9:35 a.m. ET.

A webcast of the event will be available in the “News” section of the Company’s website at https://renagadetx.com/news/. A replay of the webcast will be archived on the Company’s website for 90 days following the presentation date.

About ReNAgade Therapeutics

ReNAgade exists to unlock the potential for RNA medicines to treat disease anywhere in the body. We combine our novel RNA delivery platforms with a comprehensive RNA platform allowing for an all-RNA system for coding, editing, and gene insertion to develop new medicines.

To accelerate the future of medicine, we bring together a team with deep RNA and delivery expertise to develop paradigm-shifting RNA medicines.

ReNAgade Therapeutics—RNA Without Limits

For more information about the company, its technologies, and its leadership, visit www.renagadetx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240222038547/en/

Website: https://renagadetx.com/ View Korean version of this release Contact ReNAgade Therapeutics
Investor Relations
Argot Partners
Emily Brabbit
(212) 600-1902
[email protected]

Media Relations
Argot Partners
Sarah Sutton
(212) 600-1902
[email protected]
This news is a press release from the provider. Korea Newswire is committed to verifying the transparency of providers and eliminating content errors. You can receive press releases from this company or in industries of interest via email and RSS for free. Subscribe> News provided byReNAgade Therapeutics Distribution Channel Health Biotechnology Pharmaceutical Event Overseas